ClinConnect ClinConnect Logo
Search / Trial NCT06961682

Effectiveness of MD on MetS Patients

Launched by ASSIUT UNIVERSITY · May 6, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of the Mediterranean Diet (MD) for people with metabolic syndrome (MetS), a condition that can lead to serious health problems like heart disease and diabetes. MetS includes issues like obesity, high blood pressure, high blood sugar, and unhealthy cholesterol levels. The trial aims to see if following the MD, which is known for being low in unhealthy fats and sugars while rich in fruits, vegetables, and whole grains, can help improve these health markers and overall well-being.

To participate in this trial, individuals must be diagnosed with metabolic syndrome, which may include having high blood pressure, prediabetes or diabetes, high cholesterol, and obesity. Those eligible must be between the ages of 65 and 74, and the trial is open to all genders. Participants can expect to follow the Mediterranean Diet and will be monitored for changes in their health. It's important to note that individuals with certain conditions, like type 1 diabetes or severe liver or kidney issues, cannot take part in this study. This trial not only aims to improve health but also encourages a healthier lifestyle that can have a positive impact on daily living.

Gender

ALL

Eligibility criteria

  • 1. Inclusion criteria:
  • All people diagnosed as metabolic syndrome
  • (Hypertension(systolic BP≥130 or Diastolic BP ≥85)
  • prediabetes fasting plasma glucose(100-125),oral glucose tolerance test(140-199)Hba1c(5.7-6.4)ADA
  • Diabetes, fasting\>125, oral glucose tolerance test\>200, Hba1c≥6.5 ADA .
  • Hyperlipidaemia(TG≥150 mg\\dl-HDL\<40 in male and \<50 in female) \[12\]
  • Obesity(waist circumference ≥102cm in male and ≥88cm in female) \[12\]
  • 2. Exclusion criteria:
  • Type 1 diabetes
  • Patients with renal or advanced liver disease(Failure)
  • Oral contraceptives, psychiatric, neurologic medications and steroid therapy
  • Patients with heart failure and presence of stent
  • Endocrine disease (Thyroid disease especially hypothyroidism-Cushing disease)

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported